文献速递儿科影像骨肌CTDR

脑瘫儿童髋部影像:低剂量CT与X线患者特异性辐射剂量估算及个体内比较

Hip Imaging in Children With Cerebral Palsy: Estimation and Intrapatient Comparison of Patient-Specific Radiation Doses of Low-Dose CT and Radiography.
PubMed 文献 · Invest Radiol · 2022-08-28

本研究对67例脑瘫患儿(70对影像检查)估算髋部低剂量CT与骨盆正位X线的患者特异性辐射剂量并进行个体内比较。结果显示低剂量CT患者特异性有效剂量为0.42±0.21 mSv,X线为0.14±0.09 mSv,前者约为后者的4倍,但绝对剂量仍很低,对患者风险极小。

要点

  • 脑瘫患儿髋部低剂量CT有效剂量约0.42 mSv,为骨盆X线(约0.14 mSv)的4倍。
  • 低剂量CT不受体位影响,可提供髋部生物真实细节,但辐射剂量高于X线。
  • 两种检查绝对剂量均很低,临床决策时可结合体位配合情况权衡使用。

核心结论

  • 髋部低剂量CT的辐射剂量约为骨盆X线的4倍,但绝对剂量仍很低,对患者风险极小。

研究设计与样本

  • 回顾性研究,纳入67例脑瘫患儿共70对髋部低剂量CT与骨盆正位X线检查,两者间隔6个月内。
  • 低剂量CT采用体重调整kVp和管电流调制,X线采用年龄/体型调整kVp/mAs。
  • 患者特异性器官剂量与有效剂量通过匹配美国国家癌症研究所CT剂量系统非参考儿童体模库,采用蒙特卡洛剂量学估算;X线采用该所X线与透视剂量系统蒙特卡洛计算。
  • 比较患者特异性剂量学与基于剂量长度乘积(CT)及剂量面积乘积(X线)的估算结果。

诊断标准与关键数值

  • 低剂量CT患者特异性有效剂量为0.42±0.21 mSv,基于剂量长度乘积的有效剂量为0.59±0.28 mSv。
  • 骨盆X线患者特异性有效剂量为0.14±0.09 mSv,基于剂量面积乘积的有效剂量为0.08±0.06 mSv。
  • 患儿年龄9.1±3.3岁。

临床应用与阅片要点

  • 脑瘫患儿髋部监测选择检查方式时,需权衡低剂量CT体位无关的准确性优势与其约为X线4倍的辐射剂量。
  • 低剂量CT绝对剂量很低,不应因辐射顾虑而完全排斥其在体位配合困难患儿中的应用。

局限性

  • 回顾性研究,样本来自单中心影像数据库。
  • 剂量估算基于体模匹配和蒙特卡洛模拟,非直接物理测量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Hip displacement is the second most common orthopedic problem affecting children with cerebral palsy (CP). Routine radiographic hip surveillance typically involves an anteroposterior (AP) pelvis radiograph. Unfortunately, this imaging protocol is limited by its projectional technique and the positioning challenges in children with CP. Alternatively, hip low-dose computed tomography (LDCT) has been advocated as a more accurate strategy for imaging surveillance as it provides biofidelic details of the hip that is independent of patient positioning. However, the tradeoff is the (presumed) higher radiation dose to the patient. The goal of this study is to estimate patient-specific radiation doses of hip LDCTs and AP pelvis radiographs in CP patients, and perform an intrapatient dose comparison.

MATERIALS AND METHODS: A search of our imaging database was performed to identify children with CP who underwent hip LDCT and AP pelvis radiograph within 6 months of each other. The LDCTs were performed using weight-adjusted kVp and tube current modulation, whereas the radiographs were obtained with age-/size-adjusted kVp/mAs. The patient-specific organ and effective doses for LDCT were estimated by matching the patients to a nonreference pediatric phantom library from the National Cancer Institute Dosimetry System for Computed Tomography database with Monte Carlo-based dosimetry. The patient-specific organ and effective doses for radiograph were estimated using the National Cancer Institute Dosimetry System for Radiography and Fluoroscopy with Monte Carlo-based dose calculation. Dose conversion k-factors of dose area product for radiography and dose length product for LDCT were adapted, and the estimation results were compared with patient-specific dosimetry.

RESULTS: Our study cohort consisted of 70 paired imaging studies from 67 children (age, 9.1 ± 3.3 years). The patient-specific and dose length product-based effective doses for LDCT were 0.42 ± 0.21 mSv and 0.59 ± 0.28 mSv, respectively. The patient-specific and dose area product-based effective doses for radiography were 0.14 ± 0.09 mSv and 0.08 ± 0.06 mSv, respectively.

CONCLUSIONS: The radiation dose for a hip LDCT is ~4 times higher than pelvis radiograph, but it is still very low and poses minimal risk to the patient.

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Nosrati, Zhang, Callahan, et al. Hip Imaging in Children With Cerebral Palsy: Estimation and Intrapatient Comparison of Patient-Specific Radiation Doses of Low-Dose CT and Radiography. Invest Radiol. 2022. PMID: 36070536. doi:10.1097/RLI.0000000000000920

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。